Marvel Biosciences

Marvel Biosciences is a life sciences company that focuses on the discovery and development of a synthetic derivative compound. It offers chemical entities that inhibit the A2a adenosine receptor for neurological diseases, non-alcoholic steatohepatitis (NASH), and cancer.